Carl Zeiss Meditec AG

PNK: CZMWF · Real-Time Price · USD
64.16
-4.42 (-6.45%)
At close: May 07, 2025, 10:22 AM

Carl Zeiss Meditec Income Statement

Financials in EUR. Fiscal year is October - September.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
490.5M 579.63M 539.34M 947.2M 475M 579.7M 535.12M 504.22M 470.3M 569.94M 477.5M 445.23M 410.2M 448.58M 430.83M 398.46M 368.9M
Cost of Revenue
238.4M 289.5M 245.87M 219.58M 222.5M 239.44M 219.15M 212.05M 212.9M 200.64M 220.54M 176.65M 177.4M 180.77M 169.46M 167.7M 161.6M
Gross Profit
252.1M 290.13M 293.47M 727.62M 252.5M 340.26M 315.97M 292.17M 257.4M 369.3M 256.95M 268.57M 232.8M 267.81M 261.38M 230.75M 207.3M
Operating Income
28M 31.85M 54.39M 108.2M 58.6M 119.61M 135.61M 97.46M 75.9M 144.28M 90.47M 122.24M 56.1M 80.42M 118.43M 81.14M 68.4M
Interest Income
1.7M 4.17M 2.05M 7.76M 9.3M 12.35M 7.7M 5.51M 4.4M 6.55M 1.01M 5.41M 300K 262K 301K 463K 500K
Pretax Income
20.1M 69.47M 49.32M 67.34M 54.7M 116.46M 132.34M 90.71M 73M 140.99M 88.33M 120.1M 54.1M 77.05M 116.27M 79.09M 66.6M
Net Income
15.7M 60.73M 34.13M 46.48M 37.4M 85.2M 92.15M 62M 51M 102.71M 62.53M 90.73M 37.9M 54.08M 81.59M 54.31M 46.3M
Selling & General & Admin
148.7M 173.51M 154.81M 119.67M 121.2M 139.16M 124.47M 124.3M 116.1M 133.26M 111.09M 95.84M 97.9M 111.48M 86.29M 84.08M 82.1M
Research & Development
77.5M 84.69M 84.29M 86.33M 87.8M 93.68M 90.39M 84.25M 81M 87.17M 73.97M 69.69M 60.5M 65.57M 54.93M 57.4M 54.2M
Other Expenses
-2.1M 81K n/a -839M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
224.1M 258.28M 239.08M 839M 209M 237.14M 214.85M 208.55M 197.1M 221.42M 185.27M 165.62M 158.4M 177M 141.26M 141.49M 133.9M
Interest Expense
6.9M 9.42M 8.06M 8.06M 3.9M 3.15M 3.27M 6.75M 2.9M 3.29M 2.14M 2.14M 2M 3.37M 2.17M 2.04M 1.8M
Selling & Marketing Expenses
120.5M 139.6M 118.21M 99.15M 101.2M 114.48M 106.22M 101.85M 97.7M 106.78M 92.81M 77.52M 83.1M 93.03M 72.9M 69.09M 68.2M
Cost & Expenses
462.5M 547.77M 483.8M 839M 431.5M 476.58M 434M 420.6M 410M 422.06M 405.82M 342.27M 335.8M 357.77M 310.72M 309.19M 295.5M
Income Tax Expense
5.2M 6.61M 15.9M 20.23M 18M 30.36M 40.3M 27.42M 22.5M 37.18M 26.33M 28M 16.1M 22.23M 35.07M 23.92M 20.3M
Shares Outstanding (Basic)
87.22M 89.74M 89.74M 89.38M 89.05M 89.44M 89.38M 89.44M 89.47M 89.44M 89.33M 89.44M 90.24M 89.44M 88.28M 89.03M 89.04M
Shares Outstanding (Diluted)
87.22M 89.74M 89.74M 89.38M 89.05M 89.44M 89.38M 89.44M 89.47M 89.72M 89.33M 89.83M 90.24M 89.82M 88.28M 89.03M 89.04M
EPS (Basic)
0.18 0.68 0.38 0.94 0.42 1.98 1.03 1.26 0.57 1.15 0.70 1.01 0.42 1.52 0.92 0.61 0.52
EPS (Diluted)
0.18 0.68 0.38 0.52 0.42 1.98 1.03 1.26 0.57 1.14 0.70 1.01 0.42 1.52 0.92 0.61 0.52
EBITDA
27M 78.89M 57.38M 75.39M 58.6M 119.61M 135.61M 97.46M 75.9M 144.28M 90.47M 122.24M 56.1M 80.42M 118.43M 104.03M 68.4M
EBIT
27M 78.89M 57.38M 75.39M 58.6M 119.61M 135.61M 97.46M 75.9M 144.28M 90.47M 122.24M 56.1M 80.42M 118.43M 81.14M 68.4M
Depreciation & Amortization
n/a n/a 2.99M -32.8M 5.41M 36.81M 5.15M 37.25M 5.15M 36.72M 4.64M 33.05M 4.64M 31.66M 5.78M 29.92M 5.78M